Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non‐alcoholic fatty liver disease patients

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Liver international (Print)

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1478-3231.2011.02488.xPMID 21457446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?

  2008cited by this paper
• Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

  2008cited by this paper
• Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

  2008cited by this paper
• [Liver disease in obese patients].

  2007cited by this paper
• Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future

  2007influential reference
• Incidence and natural course of fatty liver in the general population: The Dionysos study

  2007cited by this paper
• Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.

  2007cited by this paper
• NAFLD and hyperinsulinemia are major determinants of serum ferritin levels.

  2007cited by this paper
• Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

  2006cited by this paper
• [Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].

  2006cited by this paper
• [Prevalence of non-alcoholic steatohepatitis (NASH) among biopsied cases of a urban hospital in Japan: significance of measurement of serum ferritin in the detection of NASH].

  2006cited by this paper
• The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases

  2006cited by this paper
• Pathology of nonalcoholic steatohepatitis.

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

  2005cited by this paper
• Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

  2005cited by this paper
• Long term prognosis of fatty liver: risk of chronic liver disease and death

  2004cited by this paper
• Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients

  2004cited by this paper
• Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

  2004cited by this paper
• Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

  2004cited by this paper
• The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease.

  2004cited by this paper
• Should a liver biopsy be done in patients with subclinical chronically elevated transaminases?

  2004cited by this paper
• Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.

  2004cited by this paper
• Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

  2003cited by this paper
• Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.

  2003cited by this paper
• Nonalcoholic steatohepatitis: risk factors for liver fibrosis.

  2002cited by this paper
• The risk factors of fibrosis in nonalcoholic steatohepatitis.

  2002cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

  2002cited by this paper
• Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels

  2002cited by this paper
• NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

  2002cited by this paper
• Non‐alcoholic fatty liver disease

  2002cited by this paper
• Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis

  2002cited by this paper
• Nonalcoholic Steatohepatitis: Definition and Pathology

  2001cited by this paper
• Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

  2001cited by this paper
• Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis

  2001cited by this paper
• Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.

  2001cited by this paper
• Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.

  2001cited by this paper
• Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

  2001cited by this paper
• Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity.

  2000cited by this paper
• Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

  1999cited by this paper
• Association of nonalcoholic fatty liver disease with insulin resistance.

  1999cited by this paper
• Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.

  1999cited by this paper
• Non-alcoholic steatohepatitis (NASH)

  1999cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Serum Ferritin as a Component of the Insulin Resistance Syndrome

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.

  1998cited by this paper
• Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

  1998cited by this paper
• The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern.

  1997cited by this paper
• REVIEW: Nonalcoholic steatohepatitis

  1997cited by this paper
• The prevalence of hereditary haemochromatosis in a diabetic population.

  1997cited by this paper
• The natural history of nonalcoholic fatty liver: A follow‐up study

  1995cited by this paper
• Serum ferritin and transferrin saturation in patients with chronic alcoholic and non‐alcoholic liver diseases

  1994cited by this paper
• Nonalcoholic steatohepatitis: an expanded clinical entity.

  1994cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

  1990cited by this paper
• Interactions between isolated hepatocytes and kupffer cells in iron metabolism: A possible role for ferritin as an iron carrier protein

  1988cited by this paper
• Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.

  1987cited by this paper
• Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

  1980cited by this paper

• Risk factors of metabolic dysfunction-associated steatotic liver disease in a cohort of patients with chronic hepatitis B.

  2025cites this paper
• Epicardial Adipose Tissue and Liver Fibrosis in Patients With Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Liver Disease

  2025cites this paper
• Elevated serum ferritin as a predictor of complications in cirrhotic patients: a retrospective cohort study

  2025cites this paper
• Use of Transient Elastography in Assessment of Non Alcoholic Fatty Liver Disease

  2024cites this paper
• Dose–response relationship of serum ferritin and dietary iron intake with metabolic syndrome and non-alcoholic fatty liver disease incidence: a systematic review and meta-analysis

  2024cites this paper
• Factors associated with pre-treatment hyperferritinemia in patients with chronic hepatitis C virus infection

  2024cites this paper
• Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study

  2024cites this paper
• Association between Serum Ferritin Levels and Metabolic-associated Fatty Liver Disease in Adults: a Cross-sectional Study Based on the NHANES

  2024cites this paper
• Potential mediation effect of insulin resistance on the association between iron metabolism indicators and non‐alcoholic fatty liver disease

  2024cites this paper
• Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH.

  2024cites this paper
• Real-time detection of plasma ferritin by electrochemical biosensor developed for biomedical analysis.

  2023cites this paper
• A Current Approach to Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients

  2023cites this paper
• Associations between metabolic hyperferritinaemia, fibrosis‐promoting alleles and clinical outcomes in steatotic liver disease

  2023cites this paper
• Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments

  2023cites this paper
• Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery

  2023cites this paper
• Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study

  2023cites this paper
• Nutritional Status of Vegetarian Patients Before and After Bariatric Surgery: a Monocentric Retrospective Observational Case–Control Study

  2023cites this paper
• Iron as a therapeutic target in chronic liver disease

  2023cites this paper
• Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study

  2023cites this paper
• Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease

  2022cites this paper
• IS HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE >2.5 A DISTINGUISHED CRITERIA FOR METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IDENTIFICATION?

  2022cites this paper
• Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review

  2022influential citation
• The association between non‐alcoholic fatty liver disease and serum ferritin levels in American adults

  2022cites this paper
• Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis

  2022cites this paper
• Hyperferritinemia Correlates to Metabolic Dysregulation and Steatosis in Chinese Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients

  2022cites this paper
• Serum Ferritin and NAFLD in Patients Undergoing Bariatric Surgery

  2022cites this paper
• Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study

  2022cites this paper
• Study of Serum Ferritin Levels in Patients with NAFLD and Its Relation to Male Gender and Smoking

  2022cites this paper
• Serum Uric Acid but Not Ferritin Level Is Associated with Hepatic Fibrosis in Lean Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease: A Community-Based Study

  2022cites this paper
• Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron

  2021influential citation
• Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH

  2021cites this paper
• Sleep disruption in nonalcoholic fatty liver disease: What is the role of lifestyle and diet?

  2021cites this paper
• Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice Guidelines

  2021influential citation
• Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• Iron Deficiency in Vegetarian and Omnivorous Individuals: Analysis of 1340 Individuals

  2021cites this paper
• Cirrhosis regression after SVR with indirect methods of fibrosis analysis: How far is it real?

  2021cites this paper
• Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study.

  2021cites this paper
• Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.

  2021cites this paper
• Age dependence of liver enzymes: an analysis of over 1,300,000 consecutive blood samples.

  2021cites this paper
• Biomarkers in Pediatric NAFLD

  2020cites this paper
• Modifiers of liver-related manifestation in the course of NAFLD.

  2020cites this paper
• Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?

  2020cites this paper
• Established and emerging factors affecting the progression of nonalcoholic fatty liver disease.

  2020cites this paper
• Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population

  2020cites this paper
• Prevalence and Factors Associated with Hepatic Iron Overload in Obese Individuals Undergoing Bariatric Surgery: a Cross-Sectional Study

  2020cites this paper
• Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity

  2020cites this paper
• Analysis of Metabolic Biomarkers in Non-Alcoholic Fatty Liver Disease (NAFLD); A Comprehensive Review

  2020cites this paper
• COMPARISON OF SERUM FERRITIN LEVELS IN NAFLD PATIENTS AND HEALTHY CONTROLS

  2020cites this paper
• Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation?

  2019cites this paper
• Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review

  2019cites this paper
• The effects of iron and zinc status on prognosis in pediatric Wilson's disease.

  2019cites this paper
• Deregulation of Hepatic Mek1/2–Erk1/2 Signaling Module in Iron Overload Conditions

  2019cites this paper
• Review article: iron disturbances in chronic liver diseases other than haemochromatosis – pathogenic, prognostic, and therapeutic implications

  2019cites this paper
• Evaluating the association of serum ferritin and hepatic iron with disease severity in non‐alcoholic fatty liver disease

  2019cites this paper
• The association of serum 25-hydroxyvitamin D concentrations with elevated serum ferritin levels in normal weight, overweight and obese Canadians

  2019cites this paper
• Emerging Circulating Biomarkers for The Diagnosis and Assessment of Treatment Responses in Patients with Hepatic Fat Accumulation, Nash and Liver Fibrosis

  2019cites this paper
• Serial liver transaminases have no prognostic value in non-alcoholic fatty liver disease.

  2019cites this paper
• Systematic review and meta‐analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non‐alcoholic fatty liver disease

  2018cites this paper
• The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non‐transfusion‐dependent thalassaemia patients

  2018cites this paper
• Evaluation of Serum Ferritin as an Independent Predictor of Non-alcoholic Steatohepatitis (NASH)

  2018influential citation
• Serum iron parameters in liver cirrhosis

  2018cites this paper
• Assessment of serum hepcidin level and iron profile in obese patients with nonalcoholic fatty liver disease

  2018cites this paper
• The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.

  2018cites this paper
• Stratified medicine : an exploration of the utility of non-invasive serum markers for the management of chronic liver diseases

  2018cites this paper
• Hepatic iron is the major determinant of serum ferritin in NAFLD patients

  2018cites this paper
• Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation

  2018cites this paper
• Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease

  2018cites this paper
• Correlation between Serum Ferritin Level and Histopathological Disease Severity in Non-alcoholic Fatty Liver Disease

  2018cites this paper
• Serum ferritin as a non‐invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non‐alcoholic fatty liver disease

  2017cites this paper
• Red blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease

  2017cites this paper
• Relationship between serum ferritin level and transient elastography findings among patients with nonalcoholic fatty liver disease

  2017cites this paper
• Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis

  2017cites this paper
• Correction: Hyperferritinemia and Hyperuricemia May Be Associated with Liver Function Abnormality in Obese Adolescents

  2017cites this paper
• Polycystic ovary syndrome and nonalcoholic fatty liver disease

  2017cites this paper
• The rising incidence of nonalcoholic fatty liver disease.

  2017cites this paper
• Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults

  2017cites this paper
• Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients

  2017cites this paper
• Hyperferritinemia in patients with nonalcoholic fatty liver disease.

  2017cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease.

  2017cites this paper
• Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta‐analysis

  2017cites this paper
• Non-alcoholic fatty liver disease and cardiovascular risk

  2017cites this paper
• Iron overload and non-alcoholic fatty liver disease.

  2017cites this paper
• Association between Serum Ferritin level and Non Alcoholic Fatty Liver Diseases in Khartoum Sudan

  2017cites this paper
• Nonalcoholic fatty liver disease: Diagnostic biomarkers

  2017cites this paper
• Elevated serum ferritin is associated with increased mortality in non‐alcoholic fatty liver disease after 16 years of follow‐up

  2016cites this paper
• Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature.

  2016cites this paper
• High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis

  2016cites this paper
• How should hyperferritinaemia be investigated and managed?

  2016cites this paper
• Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD

  2016cites this paper
• Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients

  2016cites this paper
• Pentraxin 3 (PTX3) as a Biomarker of Bone Disease

  2016cites this paper
• Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease

  2016cites this paper
• The development of a non‐invasive model to predict the presence of non‐alcoholic steatohepatitis in patients with non‐alcoholic fatty liver disease

  2016cites this paper
• Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway

  2015cites this paper
• INTERLEUKIN 10, THYROID STATUS AND FERRITIN ARE NON-INVASIVE PROGNOSTIC BIOMARKERS FOR DIAGNOSIS OF FATTY LIVER DISEASE IN CHILDREN

  2015cites this paper
• Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

  2015cites this paper
• Iron status in obesity: An independent association with metabolic parameters and effect of weight loss.

  2015cites this paper
• Noninvasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?

  2015cites this paper
• Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.

  2015cites this paper
• Serum ferritin is elevated in advanced non-small cell lung cancer patients and is associated with efficacy of platinum-based chemotherapy.

  2014cites this paper